内皮胰岛素抵抗加重实验性牙周炎
流行病学提示糖尿病患者牙周炎更重,但机制不明。本研究探讨牙龈内皮细胞胰岛素抵抗是否参与牙周炎发病。结果显示胰岛素经PI3K/Akt/FoxO1通路下调VCAM1表达及白细胞黏附,而高糖诱导的内皮胰岛素抵抗削弱此效应,VEIRKO小鼠即使无糖尿病也出现牙槽骨丢失加重,提示内皮胰岛素抵抗通过失调VCAM1促进牙周炎进展。
要点
- 内皮胰岛素抵抗通过PI3K/Akt/FoxO1轴上调VCAM1,加重牙周炎骨丢失。
- 高糖诱导内皮选择性胰岛素抵抗,削弱胰岛素对VCAM1的抑制。
- VEIRKO小鼠无糖尿病仍出现实验性牙周炎骨丢失加重。
核心结论
- 内皮细胞胰岛素抵抗可能通过下调PI3K/Akt/FoxO1轴导致VCAM1表达失调和白细胞黏附,从而促进牙周炎进展。
研究设计与样本
- 实验性研究,使用内皮细胞、VEIRKO小鼠、HFD喂养小鼠及高糖处理细胞,比较WT与VEIRKO小鼠实验性牙周炎模型。
主要发现
- 胰岛素通过PI3K/Akt通路下调LPS或TNFα诱导的内皮细胞VCAM1表达,减少内皮细胞与白细胞黏附。
- 高糖诱导的内皮选择性胰岛素抵抗削弱胰岛素对LPS或TNFα刺激的VCAM1表达的抑制作用。
- VEIRKO小鼠牙龈中PI3K/Akt通路选择性抑制,实验性牙周炎诱导的牙槽骨丢失加重,伴Vcam1、Tnfα、Mcp-1、Rankl上调和中性粒细胞迁移增加,尽管无糖尿病。
- VEIRKO小鼠、HFD喂养小鼠牙龈、高糖处理内皮细胞及VEIRKO原代内皮细胞中胰岛素介导的FoxO1激活受抑制。
- 过表达突变型FoxO1(T24A、S256D、S316A)减弱胰岛素介导的VCAM1表达调控及内皮细胞与白细胞黏附。
临床怎么用
- 提示控制糖尿病相关胰岛素抵抗可能有助于减缓牙周炎进展,内皮PI3K/Akt/FoxO1/VCAM1轴为潜在干预靶点。
局限性
- 研究为动物和细胞实验,尚未在人体验证;具体分子机制及临床转化需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epidemiological studies suggest that the severity of periodontitis is higher in people with diabetes than in healthy individuals. Insulin resistance might play a crucial role in the pathogenesis of multiple diabetic complications and is reportedly induced in the gingiva of rodents with type 2 diabetes; however, the molecular mechanisms underlying the pathogenesis of diabetes-related periodontitis remain unclear. Therefore, we aimed to investigate whether endothelial insulin resistance in the gingiva may contribute to the pathogenesis of periodontitis as well as elucidate its underlying molecular mechanisms. We demonstrated that insulin treatment downregulated lipopolysaccharide (LPS)-induced or tumor necrosis factor α (TNFα)-induced VCAM1 expression in endothelial cells (ECs) via the PI3K/Akt activating pathway, resulting in reduced cellular adhesion between ECs and leukocytes. Hyperglycemia-induced selective insulin resistance in ECs diminished the effect of insulin on LPS- or TNFα-stimulated VCAM1 expression. Vascular endothelial cell-specific insulin receptor knockout (VEIRKO) mice exhibited selective inhibition of the PI3K/Akt pathway in the gingiva and advanced experimental periodontitis-induced alveolar bone loss via upregulation of Vcam1, Tnfα, Mcp-1, Rankl, and neutrophil migration into the gingiva compared with that in the wild-type (WT) mice despite being free from diabetes. We also observed that insulin-mediated activation of FoxO1, a downstream target of Akt, was suppressed in the gingiva of VEIRKO and high-fat diet (HFD)-fed mice, hyperglycemia-treated ECs, and primary ECs from VEIRKO. Further analysis using ECs transfected with intact and mutated FoxO1, with mutations at 3 insulin-mediated phosphorylation sites (T24A, S256D, S316A), suggested that insulin-mediated regulation of VCAM1 expression and cellular adhesion of ECs with leukocytes was attenuated by mutated FoxO1 overexpression. These results suggest that insulin resistance in ECs may contribute to the progression of periodontitis via dysregulated VCAM1 expression and cellular adhesion with leukocytes, resulting from reduced activation of the PI3K/Akt/FoxO1 axis.
引用
- Zeze T, Shinjo T, Sato K, et al. Endothelial Insulin Resistance Exacerbates Experimental Periodontitis. J Dent Res. 2023. PMID: 37448347. doi:10.1177/00220345231181539
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。